// App-Quantinova.ai

: PHENOTYPES OF MASKED HYPERTENSION ( ISOLATED AMBULATORY, ISOLATED HOME AND DUAL MASKED HYPERTENSION )

Researchers

Presenter

  • Kyriakoulis, K

Principal Investigators

  • McManus, R

  • Niiranen, T

  • Andreadis, E

  • Jula, A

  • Kollias, A

  • Lindroos, A

  • Ntineri, A

  • Schwartz, C

  • Stergiou, G.S

Medical Centers

  • Hypertension Center STRIDE-7, University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, GREECE

  • Green Templeton College & Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UNITED KINGDOM

  • National Institute for Health and Welfare, Turku, FINLAND

  • Department of Internal Medicine, University of Turku, Turku, FINLAND

  • Division of Medicine, Turku University Hospital, Turku, FINLAND

  • Hypertension and Cardiovascular Disease Prevention Center, Evangelismos General Hospital, Athens, GREECE

Locations

  • Greece

  • United Kingdom

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Masked hypertension

Biomarkers

  • Heparin-binding protein

  • Sex hormone binding globulin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved